
Eli Lilly (LLY) moves fast to secure lead in India’s obesity drug market

I'm PortAI, I can summarize articles.
Eli Lilly and Company (NYSE:LLY) is rapidly establishing its presence in India's burgeoning obesity drug market. The company is also listed among the 14 Best Pharma Dividend Stocks to Buy in 2026. With cheaper generic versions anticipated to enter the market by March next year, Eli Lilly aims to secure its competitive advantage before this influx.

